DOI: 10.1007/s00259-018-4049-5Pages: 1832-1833

Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory?

1. CHU de Bordeaux

2. Univ. Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux

3. INSERM U-1045, Centre de Recherche Cardio-Thoracique de Bordeaux

4. Hôpital du Haut-Lévèque, Service de Médecine Nucléaire

Correspondence to:
Eric Laffon
Tel: +33 5 57 65 68 38
Email: elaffon@u-bordeaux.fr

Close

Abstract

To access the full text, please Sign in

If you have institutional access, please click here

  • Accepted: May 2, 2018
  • Online: May 17, 2018

Article Tools

eanm
EJNMMI Ad